Zeptosens Licenses Reagents from Cell Signaling Technology | GenomeWeb

NEW YORK, April 19 (GenomeWeb News) - Zeptosens of Witterswil, Switzerland announced today that it has signed an agreement with Beverly, Mass.-based Cell Signaling Technology for the use of CST's reagents in Zeptosens' ZeptoMARK protein array platform.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.